UNRESECTABLE ADRENAL GLAND PHEOCHROMOCYTOMA
Clinical trials for UNRESECTABLE ADRENAL GLAND PHEOCHROMOCYTOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE ADRENAL GLAND PHEOCHROMOCYTOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE ADRENAL GLAND PHEOCHROMOCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo trial aims to stall rare, aggressive tumors
Disease control OngoingThis study is testing if adding a drug called olaparib to standard chemotherapy (temozolomide) works better to control advanced adrenal gland tumors (pheochromocytoma and paraganglioma) that have spread or cannot be removed by surgery. It will involve about 46 patients aged 12 an…
Matched conditions: UNRESECTABLE ADRENAL GLAND PHEOCHROMOCYTOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Immunotherapy tested as new hope for rare, Tough-to-Treat cancers
Disease control OngoingThis study tested whether the immunotherapy drug pembrolizumab could help control the growth of rare, advanced cancers that have spread or cannot be removed by surgery. It involved 157 patients with specific rare tumor types who had already tried standard treatments. The goal was…
Matched conditions: UNRESECTABLE ADRENAL GLAND PHEOCHROMOCYTOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC